Adverse Reactions to Radioiodine 131I Therapy of Goiter in West African Tertiary Hospital | Zendy

Yetunde Ajoke Onimode | Zendy; John Enyi Ejeh | Zendy; Akintunde T. Orunmuyi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Adverse Reactions to Radioiodine 131I Therapy of Goiter in West African Tertiary Hospital

Author(s) -

Yetunde Ajoke Onimode,

John Enyi Ejeh,

Akintunde T. Orunmuyi

Publication year - 2016

Publication title -

molecular imaging and radionuclide therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.292

H-Index - 7

eISSN - 2147-1959

pISSN - 2146-1414

DOI - 10.4274/mirt.13007

Subject(s) - medicine , adverse effect , radioiodine therapy , thyroid cancer , drug reaction , radioactive iodine , goiter , thyroid , drug , pharmacology

Radioactive iodine therapy (RAIT) is established as an efficient means of treating toxic goiter (TG) globally. The field of nuclear medicine (NM) still appears novel to many Nigerian clinicians and patients. A culturally embedded dread of radiation may raise ethical and moral concerns about potential adverse effects in the wake of RAIT in our setting. An adverse drug reaction may be described as "a response to a drug which is noxious and unintended, and which occurs at doses normally used in man". This study therefore, seeks to review adverse reactions (ARs) experienced following RAIT. We would also like to improve patient and physician education about the safety profile of RAIT.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research